SONAR: Study of Diabetic Nephropathy with Atrasentan. A Randomized, Multi-country, Multi-center, Double-blind, Parallel, Placebo-controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy.
Investigator
Aijaz Gundroo, MD Principal Investigator
Rocco C. Venuto, MD Sub-investigator